Template talk:Hallucinogens

In this article we are going to explore the topic of Template talk:Hallucinogens, which has captured the attention of various areas of study and has generated great interest both in the academic field and in society in general. Template talk:Hallucinogens has long been the subject of debate and discussion, and its relevance has become increasingly evident in recent years. This topic has aroused the interest of researchers, scientists, professionals and the general public, due to its impact on different aspects of daily life. Throughout this article, we will explore the different aspects related to Template talk:Hallucinogens, analyzing its implications, its history, its influence today and possible future scenarios around this topic.

Does everything belong here?

Should amphetamine and ritalin make it into this template

Resolved
 – I created the "Controversial hallucinogens" section in this template.

One of L. E. Hollister's criterias for establishing that a drug is hallucinogenic is that addictive craving should be absent. --David Hedlund (talk) 03:25, 23 June 2014 (UTC)

Uniformity in naming

In the interest of uniformity, please correct all N-benzyl compound naming to the established '25X-NBXXX' nomenclature. — Preceding unsigned comment added by 78.156.201.16 (talk) 19:57, 10 January 2014 (UTC)

GABA-A "agonists"

Only muscimol and gaboxadol are true GABA-A-Agonists, i.e. bind to the same site of the receptor as GABA itself. The pharmacology of ibotenic acid beside of being a prodrug to muscimol is quite unknown, as far as I know. The "Z-drugs" (es)zopliclone, zolpidem and zaleplon, on the other hand, are not direct agonists, but positive allosteric modulators, just as the benzodiazepines, which allosteric binding site on the GABA-A-receptor they also share. Since this different pharmacological actions lead to huge differences in the subjective effects of those drugs, I really don't think that they should be lumped together. --Diogenes2000 (talk) 17:01, 16 November 2014 (UTC)

Entactogens under the Psychedelics Section

The table lists quite a few entactogens as 5ht2aR agonists, which is not true. They should either get their own section or be left in their seperate templateMDMQualone (talk) 05:24, 5 June 2016 (UTC)

Semi-protected edit request on 1 December 2020

Salvinorin A is not a cannabinoid. It should be removed from the Others/Cannabinoid/Natural section. Lluxull (talk) 05:44, 1 December 2020 (UTC)

 Not done: please provide reliable sources that support the change you want to be made. Seagull123 Φ 12:24, 1 December 2020 (UTC)